Rates of COVID-19 rebound were similar in patients who did and didn’t receive antiviral drugs, and relapse wasn’t tied to worse clinical outcomes.
COVID antivirals not tied to rebound or worse outcomes
More from COVID-19More posts in COVID-19 »
.
Rates of COVID-19 rebound were similar in patients who did and didn’t receive antiviral drugs, and relapse wasn’t tied to worse clinical outcomes.